Get Meyka ProOur News
HOT
Developer Portal
Log inSign up
Meyka LogoMeyka
BETA
Meyka AI is in beta – Features are evolving, and your feedback helps us improve!
Meyka Analyst
BusinessExecutive TradesInsights & GuidesInvestingEducationMarketMarket NewsTechnical IndicatorsTechnology
Overview
Forecasting
Trending
AI Analysis
Trending
Alt-Data
New
Fundamentals
Technical Analysis
Peers
News
Overview
Forecasting
Trending
AI Analysis
Trending
Alt-Data
New
Fundamentals
Technical Analysis
Peers
News
Loading...

ABIVAX SA

AAVXF•PNK
Healthcare
Biotechnology
$115.65
$0.00(0.00%)
U.S. Market opens in 0h 42m

AAVXF News Today: Stay Updated with the Latest ABIVAX SA News in Real Time

Find AAVXF news now at Meyka AI. Stay informed with the latest ABIVAX SA stocks updates, including price news, market analysis, and expert insights.

ABVX.PA ABIVAX SA (EURONEXT) -10.97% after hours 24 Mar 2026: catalysts ahead
📅 1 month ago

ABVX.PA ABIVAX SA (EURONEXT) -10.97% after hours 24 Mar 2026: catalysts ahead

ABVX.PA stock fell 10.97% after hours to EUR 97.40; analysis, Meyka AI grade and forecasts for investors.

Read more
€107.40 ABVX.PA stock pre-market: earnings due Mar 23 may reset targets
📅 1 month ago

€107.40 ABVX.PA stock pre-market: earnings due Mar 23 may reset targets

Pre-market look at ABVX.PA stock ahead of Mar 23 earnings; price, forecasts, Meyka grade and analyst targets

Read more
Eli Lilly Set to Make €15 Billion Offer for French Biotech Abivax, Report Says
📅 4 months ago

Eli Lilly Set to Make €15 Billion Offer for French Biotech Abivax, Report Says

Eli Lilly, one of the world’s biggest pharmaceutical companies, is reportedly preparing a €15 billion offer to acquire the French biotechnology firm Abivax SA, according to recent market reports. This potential deal reflects a strategic push by Eli Lilly to expand its presence in the biotech sector, tapping into cutting‑edge research and development pipelines that…

Read more

AAVXF News FAQ

Meyka LogoMeyka

Meyka is the best AI Powered Real-Time Stock and Crypto News Platform that helps investors make decisions based on Historical Data.

Connect With Us

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer
  • Cookie Policy

Stock Market GPTs

  • Stock Research GPT
  • Stock Earnings GPT
  • Stock Screener GPT

Resources

  • Get Meyka Pro
  • Contribute
  • Contribute on Medium
  • Blog
  • Education
  • About Us
  • Contact Us
  • Upcoming Features
  • Developer Portal
  • Subscribe to Our Newsletter

Market

  • Market Overview
  • Screener
  • Senate Trades
  • Senate Disclosures
  • Earnings Calendar
  • Economic Calendar
  • Dividends Calendar
  • News
  • Press Release

Screener Ideas

  • Top Gainers
  • Top Losers
  • AI Stocks
  • Most Active
  • Unusual Volume
  • New High
  • New Low
  • REIT Stocks
  • Technology Stocks
  • Finance Stocks
  • Dividend Stocks
  • Growth Stocks
  • High ROE Stocks

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

Ads powered by Playwire

Advertise on this site.

© 2026 Meyka AI PTY LTD. All rights reserved.
Live Market Data ●Live Market Data ●